Cumberland Pharmaceuticals
Ingrid Anderson is a seasoned professional in clinical project management and research, currently serving as a Senior Clinical Project Manager at Cumberland Pharmaceuticals since May 2022. Prior to this role, Ingrid amassed over a decade of experience at Vanderbilt University Medical Center in various positions, including Research Services Consultant II, Program Manager, and Program Coordinator II, from November 2012 to May 2022. Earlier in Ingrid's career, a role as Program Manager at Sarah Cannon Research Institute lasted from February 2010 to 2012. Ingrid holds a Doctor of Philosophy (Ph.D.) in Biology from Indiana University Bloomington, obtained between 1999 and 2005, and a Bachelor's Degree in Biology from Carleton College, earned from 1995 to 1999.
This person is not in the org chart
Cumberland Pharmaceuticals
2 followers
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription products designed to improve quality of care and address unmet medical needs. With a focus on underserved niche markets, including hospital acute care and gastroenterology, they deliver products that serve patients in the U.S. market. Cumberland also makes its products available to patients internationally through select strategic partnerships. They own the worldwide rights to all their brands. While Cumberland’s commercial capabilities are focused on the U.S. market, their business development team is actively pursuing opportunities to make their brands available to patients in markets around the globe. Their primary mission is to improve upon patient care with products that offer clear advantages over existing treatments. They also strive to deliver solutions that may help reduce costs for healthcare providers and, ultimately, patients.